Skip to main content
Loading
loadingbar
Loading, Please wait..!!

Senior Peptide Chemist: End-to-End Synthesis Lead with Equity

  • Job type Posted on: Jul 09, 2026
  • Experience level Capable Labs
  • Employment type San Francisco, California
  • Employment type Onsite
  • Salary Full-time

Point Apply Here APPLY LATER

Curious about compensation?

Explore the historical salary trends, average pay, and estimated compensation for Senior Peptide Chemist: End-to-End Synthesis Lead with Equity roles in California.

View Salary Guide →

Job Title :

Senior Peptide Chemist: End-to-End Synthesis Lead with Equity

Job Type :

Full-time

Job Location :

San Francisco California United States

Remote :

No

Jobcon Logo Job Description :

Capable Labs is seeking an experienced peptide chemist to lead and scale synthesis workflows in a fast-moving early-stage environment. You will design compounds, execute reactions, purify, and prepare candidates for testing with urgency and rigor. You will work closely with founders and a team spanning MIT, Harvard Medical School, Baker Lab, and Radical Numerics, owning end-to-end processes and contributing to breakthrough readouts in vitro and in vivo. #J-18808-Ljbffr

Jobcon Logo Position Details

Posted:

Jul 09, 2026

Reference Number:

14660_E5FAA7E77D5953483D8CA91F0F48587D

Employment:

Full-time

Salary:

Not Available

City:

San Francisco

Job Origin:

APPCAST_CPC

Share this job:

  • linkedin

Jobcon Logo
A job sourcing event
In Dallas Fort Worth
Aug 19, 2017 9am-6pm
All job seekers welcome!

Senior Peptide Chemist: End-to-End Synthesis Lead with Equity    Apply

Click on the below icons to share this job to Linkedin, Twitter!

Capable Labs is seeking an experienced peptide chemist to lead and scale synthesis workflows in a fast-moving early-stage environment. You will design compounds, execute reactions, purify, and prepare candidates for testing with urgency and rigor. You will work closely with founders and a team spanning MIT, Harvard Medical School, Baker Lab, and Radical Numerics, owning end-to-end processes and contributing to breakthrough readouts in vitro and in vivo. #J-18808-Ljbffr

Loading
Please wait..!!